These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25476977)

  • 1. Postulates for validating TLR4 agonists.
    Manček-Keber M; Jerala R
    Eur J Immunol; 2015 Feb; 45(2):356-70. PubMed ID: 25476977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.
    Klett J; Reeves J; Oberhauser N; Pérez-Regidor L; Martín-Santamaria S
    Curr Top Med Chem; 2014; 14(23):2672-83. PubMed ID: 25515751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 agonists as immunomodulatory agents.
    Alderson MR; McGowan P; Baldridge JR; Probst P
    J Endotoxin Res; 2006; 12(5):313-9. PubMed ID: 17059695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.
    Dunn-Siegrist I; Tissières P; Drifte G; Bauer J; Moutel S; Pugin J
    J Biol Chem; 2012 May; 287(20):16121-31. PubMed ID: 22433865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
    Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
    Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex.
    Oblak A; Jerala R
    Mol Immunol; 2015 Feb; 63(2):134-42. PubMed ID: 25037631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
    Saitoh S; Miyake K
    Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MD-2 determinants of nickel and cobalt-mediated activation of human TLR4.
    Oblak A; Pohar J; Jerala R
    PLoS One; 2015; 10(3):e0120583. PubMed ID: 25803856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
    Maeshima N; Fernandez RC
    Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
    Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
    Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
    Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
    J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles.
    Manček-Keber M; Frank-Bertoncelj M; Hafner-Bratkovič I; Smole A; Zorko M; Pirher N; Hayer S; Kralj-Iglič V; Rozman B; Ilc N; Horvat S; Jerala R
    Sci Signal; 2015 Jun; 8(381):ra60. PubMed ID: 26082436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
    Marr N; Turvey SE
    Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.